Agenus Inc. · Lexington, MA United States (NASDAQ: AGEN)
| 3 Forbes Rd. | Phone: 781-674-4400 |
| Lexington, MA | Fax: 781-674-4200 |
| 02421 | |
| United States | 
Map This Company |
Agenus Inc. Rankings
Company Description
Cancer and other diseases had better beware -- Agenus (formerly Antigenics) is packing heat. The firm develops heat shock proteins, which are related to the immune system's response to disease. Its patient-specific vaccines work on the theory that each person's cancer has a unique signature that can be derived from the tumor after it has been removed. The company refers to these vaccines as its Prophage Series, the lead drug candidate in the series, Oncophage, is the first personalized cancer vaccine to receive
Agenus Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: AGEN Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 56 |
Executives
15 executives listed for Agenus Inc.'s Lexington, MA location.
| Chairman and CEO | Garo Armen | |
|---|---|---|
| VP and CFO | Shalini Sharp | |
| VP Human Resources and Administration | John Cerio |